Evaluation of carotid plaque neovascularization in patients with diabetes mellitus by contrast-enhanced ultrasonography

Abstract

This study investigated the relationship between carotid plaque neovascularization and diabetes mellitus (DM) by using contrast-enhanced ultrasonography. Contrast-enhanced ultrasonography was performed in 104 patients with carotid plaque thicker than 2.0 mm. There were 36 patients with DM and 68 patients without DM. The enhanced intensity in the plaque and the ratio of enhanced intensity in the plaque to that in the lumen of the carotid artery in patients with DM were significantly greater than those in patients without DM. Our study demonstrated that the enhanced intensity in patients with DM is greater than that their counterparts without DM, suggesting that carotid plaque in DM patients may have more neovessels and may be more vulnerable.

Keywords

vulnerable plaque / contrast-enhanced ultrasonography / diabetes mellitus / neovascularization

References

[1] NaghaviM, LibbyP, FalkE, et al.. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies—Part I. Circulation, 2003, 108(14): 1664-1672

[2] MorenoPR, PurushothamanKR, FusterV, et al.. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation, 2004, 110(14): 2032-2038

[3] HaydenMR, TyagiSC. Vasa vasorun in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol, 2004, 3: 1-16

[4] CarterA, MurphyMO, TurnerNJ, et al.. Intimal neovascularization is a prominent feature of atherosclerotic plaques in diabetic patients with critical limb ischemia. Eur J Vasc Endovasc Surg, 2007, 33(3): 319-324

[5] XiongL, DengYB, ZhuY, et al.. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology, 2009, 251(2): 583-589

[6] XiongL, DengYB, BiXJ, et al.. Evaluation of carotid atherosclerotic plaque stability with contrast-enhanced ultrasonography. J Huazhong Univ Sci Technol [Med Sci], 2008, 28(6): 724-726

[7] Report of the expert committee on the diagnosis and classification of diabetes mellitus. . Diabetes Care, 2003, 26: S5-S20

[8] HigashidaT, KannoH, NakanoM, et al.. Expression of hypoxia-inducible angiogenic proteins (hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and E26 transformation-specific-1) and plaque hemorrhage in human carotid atherosclerosis. J Neurosurg, 2008, 109(1): 83-91

[9] DemyanetsS, KaunC, RychliK, et al.. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ. Basic Res Cardiol, 2011, 106(2): 217-231

[10] FeinsteinSB. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol, 2006, 48(2): 236-243

[11] VicenziniE, GiannoniMF, PuccinelliF, et al.. Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echo-contrast agent. Stroke, 2007, 38(10): 2841-2843

[12] ShahF, BalanP, WeinbergM, et al.. Contrastenhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis?. Vasc Med, 2007, 12: 291-297

[13] ColiS, MagnoniM, SangiorgiG, et al.. Contrastenhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol, 2008, 52(3): 223-230